TOUJEO, TOUJEO Max

What is this medication?

Toujeo and Toujeo Max are long-acting basal insulin glargine formulations used to improve blood sugar control in adults and children six years of age and older with diabetes mellitus. This medication works by providing a slow, steady release of insulin throughout the day and night to help manage glucose levels. It is designed for once-daily administration via subcutaneous injection and is intended to function as the primary background insulin for patients with either type 1 or type 2 diabetes.

While both Toujeo and Toujeo Max contain the same concentration of insulin at 300 units per milliliter, they differ in the delivery device and total units available. Toujeo Max SoloStar is specifically designed for patients requiring higher daily doses, as it allows for a larger maximum number of units per single injection and contains more total insulin per pen compared to the standard SoloStar version. These medications are not suitable for treating diabetic ketoacidosis and should be used under the guidance of a healthcare professional alongside a healthy diet and regular physical activity.